S

Shanghai Henlius Biotech Inc
HKEX:2696

Watchlist Manager
Shanghai Henlius Biotech Inc
HKEX:2696
Watchlist
Price: 82.25 HKD -1.26% Market Closed
Market Cap: 44.7B HKD

Wall Street
Price Targets

Price Targets Summary
Shanghai Henlius Biotech Inc

Wall Street analysts forecast Shanghai Henlius Biotech Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 100.52 HKD with a low forecast of 95.95 HKD and a high forecast of 108.06 HKD.

Lowest
Price Target
95.95 HKD
17% Upside
Average
Price Target
100.52 HKD
22% Upside
Highest
Price Target
108.06 HKD
31% Upside
Shanghai Henlius Biotech Inc Competitors:
Price Targets
ADAG
Adagene Inc
375% Upside
UTHR
United Therapeutics Corp
15% Upside
ADCT
ADC Therapeutics SA
148% Upside
AMRN
Amarin Corporation PLC
25% Downside
CANTA
Cantargia AB
142% Upside
RLAY
Relay Therapeutics Inc
196% Upside
PBYI
Puma Biotechnology Inc
2% Downside
MDXH
MDxHealth SA
58% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Henlius Biotech Inc

For the last 6 years the compound annual growth rate for Shanghai Henlius Biotech Inc's revenue is 203%. The projected CAGR for the next 3 years is 3%.

203%
Past Growth
3%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Shanghai Henlius Biotech Inc

The compound annual growth rate of Shanghai Henlius Biotech Inc's operating income for the next 3 years is 2%.

N/A
Past Growth
2%
Estimated Growth
Estimates Accuracy
45%
Average Beat

Net Income
Forecast

Net Income Estimate
Shanghai Henlius Biotech Inc

The compound annual growth rate of Shanghai Henlius Biotech Inc's net income for the next 3 years is 3%.

N/A
Past Growth
3%
Estimated Growth
Estimates Accuracy
39%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Henlius Biotech Inc's stock price target?
Price Target
100.52 HKD

According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 100.52 HKD with a low forecast of 95.95 HKD and a high forecast of 108.06 HKD.

What is Shanghai Henlius Biotech Inc's Revenue forecast?
Projected CAGR
3%

For the last 6 years the compound annual growth rate for Shanghai Henlius Biotech Inc's revenue is 203%. The projected CAGR for the next 3 years is 3%.

What is Shanghai Henlius Biotech Inc's Operating Income forecast?
Projected CAGR
2%

The compound annual growth rate of Shanghai Henlius Biotech Inc's operating income for the next 3 years is 2%.

What is Shanghai Henlius Biotech Inc's Net Income forecast?
Projected CAGR
3%

The compound annual growth rate of Shanghai Henlius Biotech Inc's net income for the next 3 years is 3%.

Back to Top